London Met’s Cancer Pharmacology master's course explores the nature of cancer at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and how they work. By the end of the MSc, you will have developed a deep understanding of how chemotherapeutic agents are used to target and kill cancer cells as part of a central strategy in the treatment of cancers.
In the most recent Destinations of Leavers from Higher Education (DLHE) survey, 100% of all 2017 graduates from this course were in work or further study within six months.
With worldwide cancer rates increasing and expected to reach 22 million new cases per year by 2030, this postgraduate course introduces you to how radiotherapy, surgery and chemotherapy have a vital role to play in prolonging the lives of patients.
We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving. You’ll also review the biology of cancer with respect to genetics, pathological considerations and the molecular changes within cells which are associated with the progression of the disease.
You'll be taught by staff who are experienced researchers in areas such as cancer biology, immunology, genetics and bioinformatics. They will help you learn how to collect, analyse, interpret and understand scientific data you must make use of in the cancer pharmacology field. This ensures you’ll not only improve your intellectual knowledge but your practical skills as well.
Your laboratory-based project will be conducted in our £30 million Science Centre. This includes access to extensive cell culture facilities, electrophoresis equipment, polymerase chain reaction (PCR) cyclers and high performance liquid chromatography (HPLC) instrumentation.
Overall, this programme of advanced study provides you with the necessary skills, knowledge and understanding for you to pursue a career in anti-cancer drug development.
Assessment on this master's course is completed through a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.
You will be required to have:
All applicants must be able to demonstrate proficiency in the English language. Applicants who require a Tier 4 student visa may need to provide a Secure English Language Test (SELT) such as Academic IELTS. For more information about English qualifications please see our English language requirements.
The modules listed below are for the academic year 2018/19 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.
Year 1 modules include:
This module provides an advanced understanding of the pharmacodynamics of therapeutic agents in the treatment of cancer.
This module provides an understanding of the clinical aspects of oncology, focusing on diagnosis and staging of different cancers, and the range of options open for therapy.
This module focuses on human diseases with a genetic component, from monogenic disorders to complex, multifactorial diseases. Consideration is also given to hereditary mechanisms not linked to DNA sequence (e.g. genomic imprinting).
This module provides an advanced understanding of cancer at the molecular level.
This module provides an opportunity for student-lead problem solving applying knowledge acquired to a specific research question.
Teaching period: Autumn, Spring, or Summer
The module is designed to provide students with an understanding of skills needed for the planning, organisation and practice of research in science. Different analytical approaches to problems will be reviewed together with the need to consider statistics and quality control in the design of projects. Students will consider the impact of appropriate safety, ethical and resourcing implications in the design and operation of a project.
This module provides an advanced understanding of drug formulation technologies.
The module uses online databases and software to extract, analyse and interpret DNA and protein sequences and to model structures of proteins.
This module is to provide an up-to-date understanding of chemical and biological technologies used in the drug discovery process.
The MSc is a one year, full-time course involving 30 weeks of taught modules divided into two 15-week semesters. The part-time mode follows a similar pattern over two years. You take five core modules, one optional module plus a research project.
Our graduates primarily go on to pursue a career in anti-cancer drug development in academia or the pharmaceutical industry. The programme also provides an excellent basis for further research or study.
Please note, in addition to the tuition fee there may be additional costs for things like equipment, materials, printing, textbooks, trips or professional body fees.
Additionally, there may be other activities that are not formally part of your course and not required to complete your course, but which you may find helpful (for example, optional field trips). The costs of these are additional to your tuition fee and the fees set out above and will be notified when the activity is being arranged.
Use the apply button to begin your application.
Please note, fees and course details may be subject to change.
You are advised to apply as early as possible as applications will only be considered if there are places available on the course.
Please select when you would like to start: